{
    "title": "Epidemic response group to invest up to $384 mln in Novavax's COVID-19 vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8309227/Epidemic-response-group-invest-384-mln-Novavaxs-COVID-19-vaccine.html",
    "date": "2020-05-11",
    "keywords": [
        "vaccine",
        "covid19",
        "development",
        "coalition",
        "company",
        "cepi",
        "university",
        "midstage",
        "novavax",
        "preparedness",
        "monday",
        "trading",
        "march",
        "oxford",
        "respiratory",
        "illness",
        "coronavirus",
        "funding",
        "candidate",
        "testing",
        "production",
        "end",
        "earlystage",
        "trial",
        "month",
        "australia",
        "topline",
        "july",
        "cepis",
        "investment",
        "research",
        "statement",
        "httpsbitly35qymnk",
        "queensland",
        "reporting",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}